Sign inJoin waitlistJoin the waitlist

DA

David Alberts

Credentials: · ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the…
Journal of Clinical Oncology · 2000 · Last of 10 authors · 1,809 citations
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Nature · 2000 · 1,355 citations
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs
New England Journal of Medicine · 1978 · 1,068 citations

ES
Earl Surwit
42 papers
FM
Frank Meyskens
34 papers
MM
Maurie Markman
26 papers
EH
Edward Hannigan
20 papers
James Warneke
20 papers
Sharon Wilczynski
18 papers
PL
Peter Lance
16 papers
DE
David Earnest
15 papers
Scott Lippman
14 papers · 2 as a resident
Robert Krouse
13 papers
Robert O'Toole
13 papers
Anil Prasad
11 papers

Grants

Cancer Prevention and Control Health Disparities Training Program
National Cancer Institute · T32
Contact PI · $912.6K · University of Arizona
2016–2022
2/2 Partnership for Native American Cancer Prevention
National Cancer Institute · U54
Contact PI · $12M · University of Arizona
2009–2019
Chemoprevention of Skin Cancer Program Project
National Cancer Institute · P01
Contact PI · $58.2M · University of Arizona
1980–2017
Cancer Prevention and Control Translational Research
National Cancer Institute · R25
Contact PI · $6.1M · University of Arizona
1998–2016

Clinical trials

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Principal investigator · Unknown · Phase 3
Gynecologic Oncology Group
2012
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer
Principal investigator · Completed · Phase 1
University of Arizona
2007–2012
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
Principal investigator · Terminated · Phase 2
Eleison Pharmaceuticals LLC.
2007–2008
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
Principal investigator · Completed · Phase 2
Gynecologic Oncology Group
2005